ATDC/TRIM29 phosphorylation by ATM/MAPKAP kinase 2 mediates radioresistance in pancreatic cancer cells

Cancer Research

Volumn 74, Issue 6, 2014, Pages 1778-1788

  Wang, Lidong ^a,f   Yang, Huibin ^a,d   Palmbos, Phillip L ^c,d   Ney, Gina ^a,e,f   Detzler, Taylor Ann ^a   Coleman, Dawn ^a   Leflein, Jacob ^a   Davis, Mary ^a   Zhang, Min ^a   Tang, Wenhua ^a   Hicks, J Kevin ^b   Helchowski, Corey M ^b   Prasad, Jayendra ^a,e   Lawrence, Theodore S ^a   Xu, Liang ^a,g   Yu, Xiaochun ^c   Canman, Christine E ^b   Ljungman, Mats ^a,e   Simeone, Diane M ^a,d,f  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b Dept of Pharmacology ^*  (United States)

^c Internal Medicine   (United States)

^d Molecular and Integrative Physiology   (United States)

^e Translational Oncology Program   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; MAP KINASE ACTIVATED PROTEIN KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; PEPTIDES AND PROTEINS; PROTEIN P53; SYNAPTOPHYSIN; TRIPARTITE MOTIF CONTAINING PROTEIN 29; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATDC GENE; CANCER CELL; CONTROLLED STUDY; DNA DAMAGE; DNA FLANKING REGION; DNA REPAIR; EMBRYO; GENE; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE SILENCING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; IONIZING RADIATION; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIATION PROTECTION; RADIOSENSITIVITY; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; DNA-BINDING PROTEINS; HEK293 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; PANCREATIC NEOPLASMS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; RADIATION TOLERANCE; TRANSCRIPTION FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84896497591     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-2289     Document Type: Article

References (30)

1. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003;421:499-506. (Pubitemid 36168436)
2. Matsuoka S, Ballif BA, Smogorzewska A,McDonald ER, Hurov KE, Luo J, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007;316:1160-6. (Pubitemid 46877472)
3. Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP, et al. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 2005;123:1213-26. (Pubitemid 41821780)
4. Lim DS, Kim ST, Xu B, Maser RS, Lin J, Petrini JH, et al. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 2000;404:613-7. (Pubitemid 30205060)
5. Wang B, Matsuoka S, Carpenter PB, Elledge SJ. 53BP1, a mediator of the DNA damage checkpoint. Science 2002;298:1435-8. (Pubitemid 35346146)
6. Ljungman M. Activation of DNA damage signaling. Mutat Res 2005; 577:203-16. (Pubitemid 41225500)
7. Kyriakis JM, Avruch J. Mammalian mitogen-Activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001;81:807-69. (Pubitemid 32267078)
8. Raman M, Earnest S, Zhang K, Zhao Y, Cobb MH. TAO kinases mediate activation of p38 in response to DNA damage. Embo J 2007;26:2005-14. (Pubitemid 46625802)
9. Reinhardt HC, Aslanian AS, Lees JA, Yaffe MB. p53-deficient cells rely on ATM-And ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell 2007;11:175-89.
10. Lafarga V, Cuadrado A, Lopez de Silanes I, Bengoechea R, Fernandez-Capetillo O, Nebreda AR, et al. p38 Mitogen-Activated protein kinaseand HuR-dependent stabilization of p21(Cip1) mRNA mediates the G (1)/S checkpoint. Mol Cell Biol 2009;29:4341-51.
11. Manke IA, Nguyen A, Lim D, Stewart MQ, Elia AE, Yaffe MB, et al. MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol Cell 2005;17:37-48. (Pubitemid 40075363)
12. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics CA Cancer J Clin 2011;60:277-300.
13. Goodman KA, Hajj C. Role of radiation therapy in the management of pancreatic cancer. J Surg Oncol 2013;107:86-96.
14. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003;63:2649-57. (Pubitemid 36605209)
15. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, et al. The tripartite motif family identifies cell compartments. Embo J 2001; 20:2140-51. (Pubitemid 32410584)
16. Nisole S, Stoye JP, Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 2005;3:799-808. (Pubitemid 41518740)
17. Wolf D, Goff SP. TRIM28 mediates primer binding site-Targeted silencing of murine leukemia virus in embryonic cells. Cell 2007;131:46-57. (Pubitemid 47498526)
18. Wang L, Heidt DG, Lee CJ, Yang H, Logsdon CD, Zhang L, et al. Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization. Cancer Cell 2009; 15:207-19.
19. Kapp LN, Painter RB. Stable radioresistance in ataxia-Telangiectasia cells containing DNA from normal human cells. Int J Radiat Biol 1989;56:667-75. (Pubitemid 20002013)
20. Kapp LN, Painter RB, Yu LC, van Loon N, Richard CW, James MR, et al. Cloning of a candidate gene for ataxia-Telangiectasia group D. Am J Hum Genet 1992;51:45-54.
21. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995;268:1749-53.
22. Kim ST, Lim DS, Canman CE, Kastan MB. Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem 1999;274:37538-43. (Pubitemid 30026807)
23. Xu L, Huang CC, Huang W, Tang WH, Rait A, Yin YZ, et al. Systemic tumor-Targeted gene delivery by anti-Transferrin receptor scFv-immunoliposomes. Mol Cancer Ther 2002;1:337-46.
24. Xu L, Yang D, Wang S, Tang W, Liu M, Davis M, et al. (-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer. Mol Cancer Ther 2005;4: 197-205. (Pubitemid 40340199)
25. Dai Y, Liu M, Tang W, DeSano J, Burstein E, Davis M, et al. Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis. Clin Cancer Res 2008;14:7701-10.
26. Lee CJ, Spalding AC, Ben-Josef E, Wang L, Simeone DM. In vivo bioluminescent imaging of irradiated orthotopic pancreatic cancer xenografts in nonobese diabetic-severe combined immunodeficient mice: a novel method for targeting and assaying efficacy of ionizing radiation. Transl Oncol 2010;3:153-9.
27. Bulavin DV, Higashimoto Y, Popoff IJ, Gaarde WA, Basrur V, Potapova O, et al. Initiation of a G2/Mcheckpoint after ultraviolet radiation requires p38 kinase. Nature 2001;411:102-7. (Pubitemid 32428198)
28. Leonhardt EA, Kapp LN, Young BR, Murnane JP. Nucleotide sequence analysis of a candidate gene for ataxia-Telangiectasia group D (ATDC). Genomics 1994;19:130-6. (Pubitemid 24034376)
29. Yuan Z, Villagra A, Peng L, Coppola D, Glozak M, Sotomayor EM, et al. The ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functions. Mol Cell Biol 2010;30:3004-15.
30. Bertrand-Vallery V, Belot N, Dieu M, Delaive E, Ninane N, Demazy C, et al. Proteomic profiling of human keratinocytes undergoing UVBinduced alternative differentiation reveals TRIpartite Motif Protein 29 as a survival factor. PLoS ONE 2010;5:e10462.